9 d. ago Ambuja Cement, JK Cement Are Dolat Capital's Top Picks In Cement Space; Q2 Results Review

Dolat Capital is optimistic about Ambuja Cement, JK Cement post Q2 results - check details

Politics

1 week ago Natco Pharma Q2: Stock Correction Warrants Dolat Capital's 'Add' Upgrade

With the recent stock correction, Dolat Capital believes there is an upside and upgrade rating to 'Accumulate' from Sell.

Events

1 week ago Granules India Q2 Review: Dolat Capital Maintains 'Add', Hikes Target Price

Any escalation of the warning letter on the Gagillapur facility to an import alert will lead to a downgrade in its earnings and rating, adds Dolat Capital.

Events

1 week ago Alkem Labs Q2 Review: Dolat Capital Upgrades EPS Estimate For FY26

Dolat Capital upgrades Alkem Labs' FY26E/FY27E EPS estimates by 3.5%/6.0%, assuming higher sales and Ebitda margin.

Politics

3 w. ago Westlife FoodWorld Q2 Review: Dolat Capital Upgrades To 'Add' On Attractive Valuations

Considering sharp correction in stock price, Dolat Capital upgrades Westlife FoodWorld to 'Accumulate' rating.

Politics

3 w. ago United Breweries Gets 'Reduce' From Dolat Capital Post Weak Q2 Earnings, Trims Target Price

Dolat Capital upgrades United Breweries by a notch to 'Reduce' from Sell rating due to price correction.

Events

3 w. ago Manappuram Finance Q2 Review: Dolat Capital Maintains 'Reduce' But Hikes Target Price

Bain Capital's strategic investment is expected to bring operational excellence, governance strength, and deeper capital access across NBFC verticals.

Economics

last month 'Sell' Sagar Cements Shares Maintains Dolat Capital Post Muted Q2 Results, Revises Target Price

Dolat Capital maintains 'Sell' rating on Sagar Cements with revised target price based on 7.0x consolidated FY28E EV/Ebitda.

Events